Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

IsoPlexis
35 NE Industrial Rd.
Branford, CT 06405
Phone: 415-971-7484
http://isoplexis.com

IsoPlexis, a privately held life sciences company, is developing novel technologies at the forefront of the revolution in immunity-based treatments of cancer. Using a next-generation diagnostic and therapeutic platform to identify patient responses at the single cell level, IsoPlexis\' original scientific leaders from Yale, Caltech, UCLA, and Memorial Sloan Kettering Cancer Center have advanced understandings of personalized therapies against various cancers. IsoPlexis is venture funded by Spring Mountain Capital, North Sound Ventures and Connecticut Innovations, as well as supported through grant funding from the National Cancer Institute and the National Institutes of Health.

Key Contact
Name
Sean Mackay
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
08/11/14 $300,000 Connecticut Innovations
undisclosed
09/25/17 $13,500,000 Series B Connecticut Innovations
Ironwood Capital
North Sound Ventures
Spring Mountain Capital
undisclosed
05/14/19 $25,000,000 Series C Connecticut Innovations
Ironwood Capital
North Sound Capital
Northpond Ventures
Spring Mountain Capital
undisclosed
01/09/20 $20,000,000 Series C Northpond Ventures
undisclosed
01/07/21 $135,000,000 Series D Ally Bridge Group
BlackRock
Perceptive Advisors
undisclosed